Guerra Jorge D, Gowarty Jasmine, Buess Jordan, Mason James, Halka Kathleen
Department of Internal Medicine, Baylor Scott & White Medical Center, Texas A&M University College of Medicine, Temple, TX, USA.
Department of Hematology and Medical Oncology, Baylor Scott & White Medical Center, Texas A&M University College of Medicine, Temple, TX, USA.
Case Rep Hematol. 2022 Mar 22;2022:9494249. doi: 10.1155/2022/9494249. eCollection 2022.
Acquired Hemophilia A (AHA) is a very rare autoimmune condition involving immune-mediated depletion of Factor VIII, resulting in spontaneous hemorrhage. Failure to recognize AHA as a possible etiology of hemorrhage can result in delayed diagnosis and treatment. The COVID-19 pandemic has given rise to several hematologic conditions and complications, with a rare manifestation being Acquired Hemophilia A (AHA). An interesting case of AHA following SARS-CoV-2 infection is described, along with the treatment approach and a brief review of several cases describing AHA in association with COVID-19.
获得性血友病A(AHA)是一种非常罕见的自身免疫性疾病,涉及免疫介导的凝血因子VIII耗竭,导致自发性出血。未能认识到AHA是出血的可能病因可导致诊断和治疗延迟。COVID-19大流行引发了几种血液学疾病和并发症,获得性血友病A(AHA)是一种罕见表现。本文描述了1例新型冠状病毒肺炎(SARS-CoV-2)感染后发生AHA的有趣病例,以及治疗方法,并简要回顾了几例描述AHA与COVID-19相关的病例。